Publication | Open Access
Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression
80
Citations
43
References
2018
Year
Molecular RegulationTumor ProgressionMolecular BiologyCancer BiologyTumor BiologyTranscriptional RegulationSignaling PathwayCell RegulationCancer Cell BiologyRadiation OncologyCell SignalingCancer ResearchEya GenesMolecular SignalingMolecular PathwayEya3 PartnersCancer GeneticsGene ExpressionCell BiologyProtein PhosphorylationSignal TransductionNatural SciencesBreast CancerC-myc StabilityTumor SuppressorMedicineCancer GrowthC-myc Stabilization
Eya genes encode a unique family of multifunctional proteins that serve as transcriptional co-activators and as haloacid dehalogenase-family Tyr phosphatases. Intriguingly, the N-terminal domain of Eyas, which does not share sequence similarity to any known phosphatases, contains a separable Ser/Thr phosphatase activity. Here, we demonstrate that the Ser/Thr phosphatase activity of Eya is not intrinsic, but arises from its direct interaction with the protein phosphatase 2A (PP2A)-B55α holoenzyme. Importantly, Eya3 alters the regulation of c-Myc by PP2A, increasing c-Myc stability by enabling PP2A-B55α to dephosphorylate pT58, in direct contrast to the previously described PP2A-B56α-mediated dephosphorylation of pS62 and c-Myc destabilization. Furthermore, Eya3 and PP2A-B55α promote metastasis in a xenograft model of breast cancer, opposing the canonical tumor suppressive function of PP2A-B56α. Our study identifies Eya3 as a regulator of PP2A, a major cellular Ser/Thr phosphatase, and uncovers a mechanism of controlling the stability of a critical oncogene, c-Myc.
| Year | Citations | |
|---|---|---|
Page 1
Page 1